What are the requirements for international applications disclosing nucleic acid or amino acid sequences?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. For international applications subject to WIPO ST.25 requirements that disclose nucleic…
Read MoreHow should naturally occurring mutations be represented in nucleic acid sequences?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. According to the table in MPEP 2412.05(c), naturally occurring mutations…
Read MoreHow are artificially introduced variations in nucleic acid sequences represented?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The MPEP 2412.05(c) provides guidance on representing artificially introduced variations…
Read MoreWhat is the requirement for exclusive conformance in sequence disclosures?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The requirement for exclusive conformance in sequence disclosures is outlined…
Read More